A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline, and Evaluation of the Impact of the Nucleoside Transporter hENT1 on Response

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Rizzieri, DA; Vey, N; Schlenk, RF; Thomas, X; Huguet, F; Gjertsen, B; Krauter, J; Blau, IW; Johansen, M; Gianelli-Borradori, A; Jacobsen, TF; Rao, J; Krug, U

Published Date

  • November 18, 2011

Published In

Volume / Issue

  • 118 / 21

Start / End Page

  • 666 - 667

Published By


  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis

Conference Location

  • San Diego, CA

Conference Start Date

  • December 10, 2011

Conference End Date

  • December 13, 2011